Back

A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma

2026-01-30 oncology Title + abstract only
View on medRxiv
Show abstract

The standard treatment for stage I lung adenocarcinoma is surgical resection, in most cases without additional systemic adjuvant treatment. A significant proportion of stage I cases recur with a less than 50% 5-year survival rate. There are clinical data suggesting that adjuvant treatment may improve survival in such recurrent cases. However, previously evaluated predictors such as the IASLC grading system from histological sections and transcriptomic profiles have not been sufficiently accurate...

Predicted journal destinations

1
Nature Communications
483 training papers
Top 0.1% 31.6%
2
Cancers
57 training papers
Top 2% 13.1%
3
Scientific Reports
701 training papers
Top 32% 7.1%
4
Frontiers in Oncology
34 training papers
Top 2% 6.6%
5
Clinical Cancer Research
22 training papers
Top 2% 5.6%
6
eLife
262 training papers
Top 9% 4.6%
7
PLOS ONE
1737 training papers
Top 84% 4.6%
8
Cancer Medicine
17 training papers
Top 3% 2.1%
9
British Journal of Cancer
22 training papers
Top 2% 2.1%
10
BMC Cancer
21 training papers
Top 3% 1.7%
11
iScience
74 training papers
Top 5% 1.5%
12
Proceedings of the National Academy of Sciences
100 training papers
Top 9% 1.5%
13
Communications Biology
36 training papers
Top 4% 0.8%
14
Cell Reports
25 training papers
Top 2% 0.8%
15
BMJ Open
553 training papers
Top 65% 0.8%
16
JAMA Network Open
125 training papers
Top 28% 0.8%
17
International Journal of Molecular Sciences
39 training papers
Top 8% 0.6%
18
Communications Medicine
63 training papers
Top 9% 0.6%
19
Journal of Clinical Investigation
50 training papers
Top 7% 0.5%
20
Aging
18 training papers
Top 3% 0.5%
21
Cell Reports Medicine
49 training papers
Top 9% 0.5%
22
Diagnostics
36 training papers
Top 8% 0.5%
23
Computers in Biology and Medicine
39 training papers
Top 12% 0.5%
24
Gut
17 training papers
Top 2% 0.5%
25
Frontiers in Immunology
140 training papers
Top 16% 0.5%
26
Nature
58 training papers
Top 13% 0.5%
27
International Journal of Cancer
18 training papers
Top 3% 0.5%
28
PLOS Computational Biology
141 training papers
Top 17% 0.5%
29
Nature Genetics
72 training papers
Top 11% 0.5%
30
PeerJ
46 training papers
Top 12% 0.5%